...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
7
Nov 02, 2020 12:01PM
5
Nov 02, 2020 12:19PM

GAC - In an ideal world ABL with its effect on ACE2 would slow or eliminate the viruses negative effects on the human body. If at the same time ABL's positive effects on heart, lung, kidney, liver, brian help combat negative effects on those systems then we may have an effective therapy that could be used for a short time of 1 to 4 weeks until we get over the virus. This would protect our pricing as a cardio/diabetes drug for what it has been originally designed. Kind of like taking cough medicine for a week or two when you get a cold.

Let's hear what they have to say at the AHA on the 13th. Maybe it works, maybe it doesn't.

tada

Share
New Message
Please login to post a reply